(Q45861916)
Statements
1 reference
The use of factor eight inhibitor by-passing activity (FEIBA immuno) product for treatment of bleeding episodes in hemophiliacs with inhibitors (English)
1 reference
Hilgartner MW
1 reference
Knatterud GL
1 reference
1 January 1983
1 reference
1 reference
61
1 reference
1
1 reference
36-40
1 reference